Axel Lennartsson

Associate
  • Stockholm
  • Languages:
    Swedish, English

Practice Areas

Mandates

Mandate January 22, 2024

Vinge advises PSG Equity in connection with its investment in Visit Group International AB

Vinge has advised the international private equity firm PSG Equity in connection with its investment…

Mandate January 09, 2024

Vinge advises Santander Consumer Finance in connection with its acquisition of Athlon Sweden AB

Vinge advises Santander Consumer Finance in connection with its acquisition of all shares in Athlon…

Mandate December 20, 2023

Vinge advises EQT X in connection with its investment in HVD Group and Next One Technology

Vinges advises the EQT X fund (or “EQT Private Equity”) in connection with its investment in the Nor…

Mandate December 12, 2023

Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB

Due Compliance is a software company which enables organisations to comply with the requirements in…

Mandate October 12, 2023

Vinge legal advisor for Advania on the acquisition of RTS

Vinge acts as legal advisor for Advania in connection with the acquisition of RTS Group AB ("RTS").

Mandate September 27, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences…

Mandate September 08, 2023

Vinge advises Altor in connection with the investment in H2 Green Steel

Vinge represents Altor in connection with its investment in H2 Green Steel. The investment has been…

Mandate January 12, 2023

Vinge advises Sobro in connection with the investment in NSS Group

Vinge advises Sobro in connection with the investment in NSS Group, a leading Nordic supplier of she…

Mandate December 19, 2022

Vinge advises Roima Intelligence Oy

Vinge advises Roima Intelligence Oy, a portfolio company of Intera Partners, in connection with the…

Mandate October 14, 2022

Vinge advises EQT Infrastructure in connection with its divestment of a minority stake in GlobalConnect to Mubadala

Vinge advises EQT Infrastructure III and IV funds (“EQT Infrastructure”) in connection with their di…

Mandate September 08, 2022

Vinge advises Lagercrantz Group in conjunction with its acquisition of Water Proof Diving International

Vinge has advised Lagercrantz Group in conjunction with its acquisition of 93% of the shares in Wate…

Mandate August 30, 2022

Vinge advises Altor in connection with the investment in H2 Green Steel

Vinge represents Altor Fund V in connection with its investment in H2 Green Steel. The investment ha…

Mandate June 07, 2022

Vinge represents Cinven and Novo Holdings in sale of Envirotainer

Vinge has represented the international private equity firm Cinven and Danish life science investmen…

Mandate May 24, 2022

Vinge advises FSN Capital and Seriline in connection with the add-on acquisition of Areff Systems

Vinge advises FSN Capital and Seriline in connection with the acquisition of Areff Systems AB from i…

Mandate March 08, 2022

Vinge has advised Insight Partners in connection with its investment by participation in a MSEK 190 investment round in Insurely

Vinge has advised Insight Partners in connection with its investment by participation in a MSEK 190…

Mandate February 23, 2022

Vinge advises FSN Capital in connection with the acquisition of Seriline

Vinge advises FSN Capital in connection with the acquisition of a majority stake in Seriline AB from…

Mandate December 15, 2021

Vinge advises Sobro in conjunction with its investment in Sluta Gräv AB

Vinge has advised Sobro in conjunction with its investment in Sluta Gräv. As the new majority shareh…

Mandate December 02, 2021

Vinge advises iBinder in connection with the acquisition of SundaHus i Linköping Aktiebolag

Vinge advises iBinder in connection with the acquisition of SundaHus i Linköping Aktiebolag ("SundaH…

Mandate November 11, 2021

Vinge advises Coloplast on the acquisition of Atos Medical

Vinge advises Danish healthcare company Coloplast on its acquisition of Atos Medical, the global mar…